Should we abandon the APTT for monitoring unfractionated heparin?
Arachchillage, D.R.J., Kamani, F., Deplano, S., Banya, W., Laffan, M.
Published in Thrombosis research (01.09.2017)
Published in Thrombosis research (01.09.2017)
Get full text
Journal Article
Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism
Arachchillage, D. R. J., Mackie, I. J., Efthymiou, M., Chitolie, A., Hunt, B. J., Isenberg, D. A., Khamashta, M., Machin, S. J., Cohen, H.
Published in Journal of thrombosis and haemostasis (01.11.2016)
Published in Journal of thrombosis and haemostasis (01.11.2016)
Get full text
Journal Article
Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome
Arachchillage, D. R. J., Efthymiou, M., Mackie, I. J., Lawrie, A. S., Machin, S. J., Cohen, H.
Published in Journal of thrombosis and haemostasis (01.11.2014)
Published in Journal of thrombosis and haemostasis (01.11.2014)
Get full text
Journal Article
Antibodies against TFPI and protein C are associated with a severe thrombotic phenotype in patients with and without antiphospholipid syndrome
Efthymiou, M., Arachchillage, D.R.J., Lane, P.J., O'Keeffe, A.G., McDonnell, T., Cohen, H., Mackie, I.J.
Published in Thrombosis research (01.10.2018)
Published in Thrombosis research (01.10.2018)
Get full text
Journal Article
Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism
Arachchillage, D.R.J, Efthymiou, M, Mackie, I.J, Lawrie, A.S, Machin, S.J, Cohen, H
Published in Thrombosis research (01.02.2015)
Published in Thrombosis research (01.02.2015)
Get full text
Journal Article
Effect of extremes of body weight on drug level in patient treated with standard dose of rivaroxaban for venous thromboembolism; real life experience
Arachchillage, D.R.J, Reynolds, R, Devey, T, Maclean, R, Kitchen, S, van Veen, J.J
Published in Thrombosis research (01.11.2016)
Published in Thrombosis research (01.11.2016)
Get full text
Journal Article
P1747Heparin anti-Xa assay versus Activated Partial Thromboplastin Time to monitor unfractionated heparin during Extra-Corporeal-Membrane-Oxygenation
Vandenbriele, C, Bhudia, N, Dhillon, E, Doyle, J, Laffan, M A, Ledot, S, Morgan, C, Murfin, B, Passariello, M, Patel, B, Pepper, J, Price, S, Singh, S, Trimlett, R, Arachchillage, D R J
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
Cohen, Hannah, Hunt, Beverley J, Efthymiou, Maria, Arachchillage, Deepa R J, Mackie, Ian J, Clawson, Simon, Sylvestre, Yvonne, Machin, Samuel J, Bertolaccini, Maria L, Ruiz-Castellano, Maria, Muirhead, Nicola, Doré, Caroline J, Khamashta, Munther, Isenberg, David A
Published in The Lancet. Haematology (01.09.2016)
Published in The Lancet. Haematology (01.09.2016)
Get more information
Journal Article